PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Optimising Outcomes With PARPs in Advanced Ovarian Cancer
Visit https://www.peervoice.com/DKF860 to view the entire programme with slides. After completing “Optimising Outcomes With PARPs in Advanced Ovarian Cancer”, participants will be able to: Describe the latest clinical findings for PARP inhibitors in the management of advanced ovarian cancer; Summarise the clinical implications of these emerging data in the management of advanced ovarian cancer; Translate clinical evidence for PARP inhibitors in advanced ovarian cancer into optimal treatment plans